JuneCH, O'ConnorRS, KawalekarOU, et al.CAR T cell immunotherapy for human cancer. Science, 2018; 359(6382):1361–1365; doi: 10.1126/science.aar6711
2.
Freen-van HeerenJJ. Using CRISPR to enhance T cell effector function for therapeutic applications. Cytokine X, 2021; 3(1):100049; doi: 10.1016/j.cytox.2020.100049
3.
DaiX, ParkJJ, DuY, et al.Massively parallel knock-in engineering of human T cells. Nat Biotechnol, 2023; doi: 10.1038/s41587-022-01639-x
4.
FraiettaJA, NoblesCL, SammonsMA, et al.Disruption of TET2 promotes the therapeutic efficacy of CD19-targeted T cells. Nature, 2018; 558(7709):307–312; doi: 10.1038/s41586-018-0178-z
5.
YoshikawaT, WuZ, InoueS, et al.Genetic ablation of PRDM1 in antitumor T cells enhances therapeutic efficacy of adoptive immunotherapy. Blood, 2022; 139(14):2156–2172; doi: 10.1182/blood.2021012714
6.
DongMB, WangG, ChowRD, et al.Systematic immunotherapy target discovery using genome-scale in vivo CRISPR screens in CD8 T cells. Cell, 2019; 178(5):1189–1204; doi: 10.1016/j.cell.2019.07.044
7.
BertusEksteen, MoraJR, HaughtonEL, et al.Gut homing receptors on CD8 T cells are retinoic acid dependent and not maintained by liver dendritic or stellate cells. Gasteroenterology, 2009; 137(1):320–329; doi: 10.1053/j.gastro.2009.02.046.Gut
8.
BonifantCL, JacksonHJ, BrentjensRJ, et al.Toxicity and management in CAR T-cell therapy. Mol Ther Oncolytics, 2016; 3:16011; doi: 10.1038/mto.2016.11
9.
StadtmauerEA, FraiettaJA, DavisMM, et al.CRISPR-engineered T cells in patients with refractory cancer. Science (80-), 2020; 367(6481); doi: 10.1126/science.aba7365
10.
LiuX, RanganathanR, JiangS, et al.A chimeric switch-receptor targeting PD1 augments the efficacy of second-generation CAR T cells in advanced solid tumors. Cancer Res, 2016; 76(6):1578–1590; doi: 10.1158/0008-5472.CAN-15-2524
11.
XieG, DongH, LiangY, et al.CAR-NK cells: A promising cellular immunotherapy for cancer. EBioMedicine, 2020; 59; doi: 10.1016/j.ebiom.2020.102975
12.
StucchiA, MaspesF, Montee-RodriguesE, et al.Engineered Treg cells: The heir to the throne of immunotherapy. J Autoimmun, 2023; 102986; doi: 10.1016/j.jaut.2022.102986
13.
Akama-GarrenEH, CarrollMC. T cell help in the autoreactive germinal center. Scand J Immunol, 2022; 95(6):1–25; doi: 10.1111/sji.13192
